{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:32:31Z","timestamp":1766313151130,"version":"3.48.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020841","name":"Envision","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019522","name":"JCR Pharmaceuticals Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019522","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymgmr.2025.101267","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:00:17Z","timestamp":1760072417000},"page":"101267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Natural history, clinical symptoms, and cognitive development of Japanese patients with mucopolysaccharidosis III"],"prefix":"10.1016","volume":"45","author":[{"given":"Joo-Hyun","family":"Seo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakana","family":"Sou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutsugu","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torayuki","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2025.101267_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TACG.S57672","article-title":"Sanfilippo syndrome: causes, consequences, and treatments","volume":"8","author":"Fedele","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2016.05.017","article-title":"Unique medical issues in adult patients with mucopolysaccharidoses","volume":"34","author":"Mitchell","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","article-title":"The natural history of neurocognition in MPS disorders: a review","volume":"133","author":"Shapiro","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0020","first-page":"201","article-title":"Mucopolysaccharidosis III: molecular basis and treatment, Pediatr. Endocrinol","volume":"27","author":"Spahiu","year":"2021","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s13023-022-02484-6","article-title":"MPS III Guideline Development Group, Sanfilippo syndrome: consensus guidelines for clinical care","volume":"17","author":"Muschol","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","article-title":"Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations \u2014 neurological signs and symptoms","volume":"122","author":"Shapiro","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0035","article-title":"Current concepts in the management of Sanfilippo syndrome (MPS III): a narrative review","volume":"16","author":"Alyazidi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","article-title":"Epidemiology of mucopolysaccharidoses","volume":"121","author":"Khan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/diagnostics11020273","article-title":"Epidemiology of mucopolysaccharidoses update","volume":"11","author":"\u00c7elik","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13023-018-0796-4","article-title":"Epidemiology of Sanfilippo syndrome: results of a systematic literature review","volume":"13","author":"Zelei","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"H\u00e9ron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in the Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1750-1172-8-189","article-title":"Natural history of Sanfilippo syndrome in Spain","volume":"8","author":"Delgadillo","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0075","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/ajmg.a.40351","article-title":"Mucopolysaccharidosis III in Taiwan: natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period","volume":"176","author":"Lin","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1515\/jpem-2019-0505","article-title":"Mucopolysaccharidosis III in mainland China: natural history, clinical and molecular characteristics of 34 patients","volume":"33","author":"Kong","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/jpm12050665","article-title":"Natural history and molecular characteristics of Korean patients with mucopolysaccharidosis type III","volume":"12","author":"Kim","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0090","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.3390\/ijms21217819","article-title":"Sanfilippo syndrome: molecular basis, disease models and therapeutic approaches","volume":"21","author":"Benet\u00f3","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2016.05.006","article-title":"A phase 1\/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA","volume":"118","author":"Jones","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(17)30169-2","article-title":"Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1\/2 clinical trial","volume":"16","author":"Tardieu","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","article-title":"Natural history of Sanfilippo syndrome type A","volume":"37","author":"Buhrman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2022.06.005","article-title":"Longitudinal natural history of pediatric subjects affected with mucopolysaccharidosis IIIB","volume":"249","author":"Okur","year":"2022","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of mucopolysaccharidosis type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpeds.2018.01.044","article-title":"Observational prospective natural history of patients with Sanfilippo syndrome type B","volume":"197","author":"Whitley","year":"2018","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2021.12.002","article-title":"An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA","volume":"135","author":"Wijburg","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1442-200X.1961.tb01032.x","article-title":"Analytic test for development in infancy and childhood","volume":"4","author":"Enjoji","year":"1961","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0135","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.anl.2018.12.003","article-title":"Developmental delays assessed using the Enjoji Scale in children with cochlear implants who have intellectual disability with or without autism spectrum disorder","volume":"46","author":"Motegi","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0140","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1038\/s41598-024-57459-3","article-title":"Relationship between serum cortisol levels, stereotypies, and the presence of autism spectrum disorder in patients with severe intellectual disability","volume":"14","author":"Ohtsubo","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0145","series-title":"Kyoto Kokusai Shakaifukushi Center","article-title":"The Guide of Kyoto Scale of Psychological Development","author":"Ikuzawa","year":"2001"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2017.05.005","article-title":"Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: a review of the literature","volume":"121","author":"Janzen","year":"2017","journal-title":"Mol. Genet. Metab."},{"author":"Leiden Open Variation Database","key":"10.1016\/j.ymgmr.2025.101267_bb0155"},{"author":"Leiden Open Variation Database","key":"10.1016\/j.ymgmr.2025.101267_bb0160"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1023\/A:1005362826552","article-title":"Identification of a common mutation (R245H) in Sanfilippo A patients from The Netherlands","volume":"21","author":"Weber","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<479::AID-HUMU10>3.0.CO;2-X","article-title":"Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A)","volume":"10","author":"Bunge","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<313::AID-HUMU9>3.0.CO;2-P","article-title":"Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations","volume":"11","author":"Di Natale","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/jnnp.73.6.777","article-title":"An adult Japanese Sanfilippo A patient with novel compound heterozygous S347F and D444G mutations in the sulphamidase gene","volume":"73","author":"Miyazaki","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgmr.2025.101267_bb0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10038-005-0258-4","article-title":"Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the \u03b1-N-acetylglucosaminidase gene from the Okinawa islands in Japan","volume":"50","author":"Chinen","year":"2005","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0190","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s100380200070","article-title":"Molecular analysis of the alpha-N-acetylglucosaminidase gene in seven Japanese patients from six unrelated families with mucopolysaccharidosis IIIB (Sanfilippo type B), including two novel mutations","volume":"47","author":"Tanaka","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0195","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jmg.35.11.910","article-title":"Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB)","volume":"35","author":"Beesley","year":"1998","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jmg.36.1.28","article-title":"Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel alpha-N-acetylglucosaminidase gene mutations","volume":"36","author":"Bunge","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13023-024-03333-4","article-title":"Health service utilization, economic burden and quality of life of patients with mucopolysaccharidosis in China","volume":"19","author":"Kang","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40120-020-00226-z","article-title":"Parent experiences of Sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment","volume":"10","author":"Porter","year":"2021","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-019-1150-1","article-title":"Analysis of the caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data","volume":"14","author":"Shapiro","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-016-0521-0","article-title":"Parents' experiences of living with, and caring for children, adolescents and young adults with mucopolysaccharidosis (MPS)","volume":"11","author":"Somanadhan","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107709","article-title":"Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: final report of 5-year results from a Japanese open-label phase 1\/2 study","volume":"140","author":"Seo","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0235","article-title":"Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan","volume":"37","author":"Hattori","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040085","article-title":"Report of five years of experience in neonatal screening for mucopolysaccharidosis type I and review of the literature","volume":"6","author":"Gragnaniello","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijns10040071","article-title":"A systematic literature review on the global status of newborn screening for mucopolysaccharidosis II","volume":"10","author":"Ayodele","year":"2024","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgmr.2025.101267_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ymgme.2021.05.004","article-title":"Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: a nationwide survey in Japan","volume":"133","author":"Koto","year":"2021","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:30:13Z","timestamp":1766313013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S2214426925000825"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101267","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history, clinical symptoms, and cognitive development of Japanese patients with mucopolysaccharidosis III","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101267"}}